Sophie Séronie-Vivien

Summary

Affiliation: Institut Claudius Regaud
Country: France

Publications

  1. doi request reprint [Consequences for clinical biochemists of the modifications of the creatinine-based evaluation of glomerular filtration rate between 2005 and 2008]
    S Seronie-Vivien
    Departement de Biologie Clinique, Institut Claudius Regaud, Universite Paul Sabatier, Toulouse, France
    Ann Biol Clin (Paris) 66:263-8. 2008
  2. doi request reprint Cystatin C: current position and future prospects
    Sophie Séronie-Vivien
    Departement de Biologie Clinique, Institut Claudius Regaud, Universite Paul Sabatier, Toulouse, France
    Clin Chem Lab Med 46:1664-86. 2008
  3. ncbi request reprint Modeling the variability of creatinine measurements improves estimates of the glomerular filtration rate
    Sophie Séronie-Vivien
    Department of Clinical Biology, Institut Claudius Regaud, Universite Paul Sabatier, Toulouse, France
    Clin Chem Lab Med 46:215-8. 2008
  4. doi request reprint [Cystatin C: current step and future prospects]
    S Seronie-Vivien
    Departement de Biologie Clinique, Institut Claudius Regaud, Universite Paul Sabatier, Toulouse, France
    Ann Biol Clin (Paris) 66:301-23. 2008
  5. ncbi request reprint Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin
    Fabienne Thomas
    Department of Clinical Biology and EA3035, Institut Claudius Regaud, Toulouse, France
    Clin Pharmacokinet 44:1305-16. 2005
  6. ncbi request reprint Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients
    Sophie Séronie-Vivien
    Department of Clinical Biology, Institute Claudius Regaud, Toulouse, France
    Med Oncol 23:63-73. 2006
  7. ncbi request reprint Pharmacokinetic-pharmacodynamic relationships of imatinib and its main metabolite in patients with advanced gastrointestinal stromal tumors
    Catherine Delbaldo
    Hospital Henri Mondor, Creteil, France, EA3035, Institut Claudius Regaud, Toulouse, France
    Clin Cancer Res 12:6073-8. 2006
  8. ncbi request reprint GFR is better estimated by considering both serum cystatin C and creatinine levels
    Yann Bouvet
    Department of Clinical Biology and EA3035, Institut Claudius Regaud, Toulouse, France
    Pediatr Nephrol 21:1299-306. 2006
  9. ncbi request reprint Serum cystatin C is a better marker of topotecan clearance than serum creatinine
    Antje Hoppe
    EA 3035 and Department of Clinical Biology, Institut Claudius Regaud, Toulouse, France
    Clin Cancer Res 11:3038-44. 2005
  10. ncbi request reprint [Interest of cystatin C for individual dosing of anticancer drugs cleared by the kidneys]
    Fabienne Thomas
    Institut Claudius Regaud, EA3035 Pharmacologie Clinique et Expérimentale des Médicaments Anti Cancéreux, et UFR de Pharmacie, Universite Paul Sabatier, 20 24 rue du Pont saint Pierre, 31052 Toulouse, France
    Therapie 62:121-7. 2007

Collaborators

Detail Information

Publications15

  1. doi request reprint [Consequences for clinical biochemists of the modifications of the creatinine-based evaluation of glomerular filtration rate between 2005 and 2008]
    S Seronie-Vivien
    Departement de Biologie Clinique, Institut Claudius Regaud, Universite Paul Sabatier, Toulouse, France
    Ann Biol Clin (Paris) 66:263-8. 2008
    ..Today, only some enzymatic methods can prove that they are traceable to the reference method. For the colorimetric methods, future is inclear...
  2. doi request reprint Cystatin C: current position and future prospects
    Sophie Séronie-Vivien
    Departement de Biologie Clinique, Institut Claudius Regaud, Universite Paul Sabatier, Toulouse, France
    Clin Chem Lab Med 46:1664-86. 2008
    ..This paper also reviews recent data about the other applications of cystatin C, particularly in cardiology, oncology and clinical pharmacology...
  3. ncbi request reprint Modeling the variability of creatinine measurements improves estimates of the glomerular filtration rate
    Sophie Séronie-Vivien
    Department of Clinical Biology, Institut Claudius Regaud, Universite Paul Sabatier, Toulouse, France
    Clin Chem Lab Med 46:215-8. 2008
    ..The precision of the formulae used to estimate glomerular filtration rate (GFR) decreases when the serum creatinine (SCr) assay is biased compared with the assay used during the development of the formulae...
  4. doi request reprint [Cystatin C: current step and future prospects]
    S Seronie-Vivien
    Departement de Biologie Clinique, Institut Claudius Regaud, Universite Paul Sabatier, Toulouse, France
    Ann Biol Clin (Paris) 66:301-23. 2008
    ..Moreover, this paper reviews the recent data about potential other applications of cystatin C, especially in cardiology, in oncology and in clinical pharmacology...
  5. ncbi request reprint Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin
    Fabienne Thomas
    Department of Clinical Biology and EA3035, Institut Claudius Regaud, Toulouse, France
    Clin Pharmacokinet 44:1305-16. 2005
    ..Carboplatin is one of the drugs for which elimination is most dependent on the GFR. A prospective clinical trial including 45 patients was conducted to assess the value of serum CysC as a predictor of carboplatin clearance (CL)...
  6. ncbi request reprint Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients
    Sophie Séronie-Vivien
    Department of Clinical Biology, Institute Claudius Regaud, Toulouse, France
    Med Oncol 23:63-73. 2006
    ..Other markers have been proposed including serum cystatin C (cysC) and the Modification of Diet in Renal Disease (MDRD) study equation...
  7. ncbi request reprint Pharmacokinetic-pharmacodynamic relationships of imatinib and its main metabolite in patients with advanced gastrointestinal stromal tumors
    Catherine Delbaldo
    Hospital Henri Mondor, Creteil, France, EA3035, Institut Claudius Regaud, Toulouse, France
    Clin Cancer Res 12:6073-8. 2006
    ..This study explored factors affecting the pharmacokinetic variability of imatinib and CGP 74588, and the pharmacokinetic-pharmacodynamic correlations in patients with advanced gastrointestinal stromal tumors...
  8. ncbi request reprint GFR is better estimated by considering both serum cystatin C and creatinine levels
    Yann Bouvet
    Department of Clinical Biology and EA3035, Institut Claudius Regaud, Toulouse, France
    Pediatr Nephrol 21:1299-306. 2006
    ..16))]. This equation was associated with a less biased and more precise estimation than the Schwartz equation. CysC improves the estimation of the GFR in children if considered with other covariates within the mathematical formula...
  9. ncbi request reprint Serum cystatin C is a better marker of topotecan clearance than serum creatinine
    Antje Hoppe
    EA 3035 and Department of Clinical Biology, Institut Claudius Regaud, Toulouse, France
    Clin Cancer Res 11:3038-44. 2005
    ..Cystatin C, a member of the cystatin superfamily of cysteine proteinase inhibitors, has been recently proposed as an alternative endogenous marker of glomerular filtration. Renal function is known as a key factor of topotecan clearance...
  10. ncbi request reprint [Interest of cystatin C for individual dosing of anticancer drugs cleared by the kidneys]
    Fabienne Thomas
    Institut Claudius Regaud, EA3035 Pharmacologie Clinique et Expérimentale des Médicaments Anti Cancéreux, et UFR de Pharmacie, Universite Paul Sabatier, 20 24 rue du Pont saint Pierre, 31052 Toulouse, France
    Therapie 62:121-7. 2007
    ..A generalisation of cystatin C assay would contribute to standardise the clinical practices in Oncology...
  11. ncbi request reprint Impact of standardized calibration on the inter-assay variation of 14 automated assays for the measurement of creatinine in human serum
    Sophie Séronie-Vivien
    Institut Claudius Regaud, Toulouse, France
    Clin Chem Lab Med 43:1227-33. 2005
    ..The aim of our study was to measure the inter-assay variation and accuracy of serum creatinine assays and to assess the effect of standardized calibration procedures on this variability...
  12. doi request reprint Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients
    Acil Jaafar
    CHU Rangueil, Department of Clinical Physiology and Université Toulouse III Paul Sabatier, Toulouse, France
    AIDS 23:257-9. 2009
    ..8%. Urinary cystatin C to urinary creatinine ratio allows to rule out a Fanconi syndrome in most cases; thus, it should be used for the safety follow-up of nucleotide reverse transcriptase inhibitor-treated patients...
  13. ncbi request reprint Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report
    Sophie Séronie-Vivien
    Department of Biology, Institut Claudius Regaud, 20 24 rue du Pont St Pierre, 31052 Toulouse Cedex, France
    Med Oncol 20:301-6. 2003
    ..This case report supports the combination of EPO and IV iron supplementation in patients with anemia of chronic disease and either an impaired iron absorption or intolerance to oral iron...
  14. ncbi request reprint A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer
    Sophie Séronie-Vivien
    INSERM U563, Centre de Physiopathologie de Toulouse Purpan, Département Innovation thérapeutique et Oncologie Moléculaire, Institut Claudius Regaud, Toulouse, France
    Clin Chem Lab Med 42:889-95. 2004
    ..8568) but poor for patients (r2=0.0563). Assessment of the OEAS/E2 ratio as a prognostic and predictive factor would be of interest in clinical prospective trials involving ER+ breast cancer patients...
  15. doi request reprint Population pharmacokinetics and pharmacogenetics of imatinib in children and adults
    Aurélie Pétain
    EA3035, Institut Claudius Regaud, Universite Paul Sabatier, Toulouse, France
    Clin Cancer Res 14:7102-9. 2008
    ..The aim of this study was to explore the effect of several demographic, biological, and pharmacogenetic covariates on the disposition of imatinib and its main metabolite (CGP74588) in both adults and children...